Our Journey
Pioneering RNA Therapeutics
Dexoligo Therapuetics was founded in 2021 by Dexcel Pharma, Israel’s largest privately held pharmaceutical company, with the vision of establishing an impactful and innovative RNA therapeutics endeavor. The Dexcel group is a leading investor in cutting-edge scientific ventures, and has been involved in the formation of numerous pioneering biomedical companies, such as Roivant Sciences, Clexio Biosciences, Kriya Therapeutics, and more.
RNA Therapeutics Vision
With the vision of establishing an impactful and innovative RNA therapeutics endeavor. The Dexcel group is a leading investor in cutting-edge scientific ventures, and has been involved in the formation of numerous pioneering biomedical companies, such as Roivant Sciences, Clexio Biosciences, Kriya Therapeutics, and more.